Biocept, Inc. (BIOC) CEO Michael Nall on Q2 2020 Results - Earnings Call Transcript
Biocept, Inc. (BIOC) CEO Michael Nall on Q2 2020 Results - Earnings Call Transcript
SeekingAlpha
0 shares
1 views
You might like
Related news coverage
Biocept says it has processed more than 20,000 COVID-19 specimens at its San Diego lab
Proactive Investors
Biocept Inc (NASDAQ:BIOC) announced Monday it has received more than 21,000 COVID-19 specimens and processed more than 20,000 to..
-
Burlington Stores, Inc. (BURL) CEO Michael O'Sullivan on Q2 2020 Results - Earnings Call Transcript
SeekingAlpha
-
Emerging companies to connect with investors via Proactive One2One Investor Forum on August 25
Proactive Investors
-
Biocept expands availability of its COVID-19 testing services via large healthcare network
Proactive Investors
-
Qualigen Therapeutics, Inc. (QLGN) CEO Michael Poirier on Q1 2021 Results - Earnings Call Transcript
SeekingAlpha
Advertisement
More coverage
-
NA Proactive news snapshot: Arcadia Biosciences, Co-Diagnostics, VolitionRx, NexTech AR, MindMed, Nerds On Site... UPDATE
Proactive Investors
-
Cengage Learning Holdings II, Inc.'s (CNGO) CEO Michael Hansen on Q1 2021 Results - Earnings Call Transcript
SeekingAlpha
-
NA Proactive news snapshot: NexTech AR, MindMed, Nerds On Site, PyroGenesis Canada, Willow Biosciences ... UPDATE
Proactive Investors
-
NA Proactive news snapshot:Willow Biosciences, Benchmark Metals, China Xiangtai Food, Mandalay Resources...
Proactive Investors